Literature DB >> 12861608

The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size.

Miechel L T Zweers1, Dirk W Grijpma, Gerard H M Engbers, Jan Feijen.   

Abstract

In local drug delivery, nanoparticles based on biodegradable polymers can function as vehicles with controlled drug-release properties. To achieve a well-controlled drug-release profile, control over the particle size is of great importance. Therefore, biodegradable polyester nanoparticles were prepared by the salting-out method. Process variables were varied to study the effect on the particle size. The monodisperse particles obtained were between 100 and 400 nm in size and spherical in shape. It was found that the particle size could be adjusted by varying the preparation conditions upon which the polymer concentration had the most pronounced effect. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861608     DOI: 10.1002/jbm.b.10046

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  18 in total

1.  Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG Nanoparticles.

Authors:  Betty Gourdon; Xavier Declèves; Jean-Manuel Péan; Caroline Chemin
Journal:  Pharm Res       Date:  2018-03-05       Impact factor: 4.200

2.  Nanoparticle-in-gel system for delivery of vitamin C for topical application.

Authors:  Sanjukta Duarah; Ramya Devi Durai; VedhaHari B Narayanan
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

3.  Tuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicin.

Authors:  Lily Yun Lin; Nam S Lee; Jiahua Zhu; Andreas M Nyström; Darrin J Pochan; Richard B Dorshow; Karen L Wooley
Journal:  J Control Release       Date:  2011-01-15       Impact factor: 9.776

4.  Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers.

Authors:  Enas El-Maghawry; Mina I Tadros; Seham A Elkheshen; Ahmed Abd-Elbary
Journal:  Int J Nanomedicine       Date:  2020-06-08

5.  Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery.

Authors:  Ndidi C Ngwuluka; Viness Pillay; Yahya E Choonara; Girish Modi; Dinesh Naidoo; Lisa C du Toit; Pradeep Kumar; Valence M K Ndesendo; Riaz A Khan
Journal:  Int J Mol Sci       Date:  2011-09-23       Impact factor: 5.923

6.  Development and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin.

Authors:  Ling-Chun Chen; Yin-Chen Chen; Chia-Yu Su; Wan-Ping Wong; Ming-Thau Sheu; Hsiu-O Ho
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

7.  Polymeric nanoparticles containing diazepam: preparation, optimization, characterization, in-vitro drug release and release kinetic study.

Authors:  Sarvesh Bohrey; Vibha Chourasiya; Archna Pandey
Journal:  Nano Converg       Date:  2016-03-01

8.  Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs).

Authors:  Tzu-Pin Li; Wan-Ping Wong; Ling-Chun Chen; Chia-Yu Su; Lih-Geeng Chen; Der-Zen Liu; Hsiu-O Ho; Ming-Thau Sheu
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

9.  Formulation and Optimization of Avanafil Biodegradable Polymeric Nanoparticles: A Single-Dose Clinical Pharmacokinetic Evaluation.

Authors:  Hibah M Aldawsari; Usama A Fahmy; Fathy Abd-Allah; Osama A A Ahmed
Journal:  Pharmaceutics       Date:  2020-06-26       Impact factor: 6.321

10.  Lipoperoxide Nanoemulsion as Adjuvant in Cisplatin Cancer Therapy: In Vitro Study on Human Colon Adenocarcinoma DLD-1 Cells.

Authors:  Stefania Vernazza; Elena Dellacasa; Sara Tirendi; Laura Pastorino; Anna Maria Bassi
Journal:  Nanomaterials (Basel)       Date:  2021-05-21       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.